286 related articles for article (PubMed ID: 9264868)
21. [Effect of low calcitonin doses on bone remodeling in postmenopausal women with high bone turnover rate].
Campusano C; López JM; Campino C; Cárdenas I; Rojas A
Rev Med Chil; 2000 Apr; 128(4):387-91. PubMed ID: 10962855
[TBL] [Abstract][Full Text] [Related]
22. [Observation of preventing of bone loss during early postmenopause by percutaneous estradiol in Chinese postmenopausal women].
Sun A; Lin S; Wei Y
Zhonghua Fu Chan Ke Za Zhi; 2001 Jun; 36(6):348-51. PubMed ID: 11783133
[TBL] [Abstract][Full Text] [Related]
23. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.
Välimäki MJ; Kinnunen K; Volin L; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Ruutu T
Bone Marrow Transplant; 1999 Feb; 23(4):355-61. PubMed ID: 10100579
[TBL] [Abstract][Full Text] [Related]
24. Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal route.
Delmas PD; Marianowski L; Perez Ade C; Ribot C; Pornel B; Palacios S; Lopes P;
Maturitas; 2004 Jun; 48(2):85-96. PubMed ID: 15172082
[TBL] [Abstract][Full Text] [Related]
25. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
Bunyavejchevin S; Limpaphayom KK
J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
[TBL] [Abstract][Full Text] [Related]
26. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
[TBL] [Abstract][Full Text] [Related]
27. [The effect of a one-year alendronate therapy on postmenopausal osteoporosis. (Results in Hungary of an international multicenter clinical study)].
Bettembuk P; Balogh A
Orv Hetil; 1999 Dec; 140(50):2799-803. PubMed ID: 10647267
[TBL] [Abstract][Full Text] [Related]
28. [Effects of the combined raloxifene-sodium fluoride therapy on bone mass and bone turnover in women with postmenopausal osteoporosis].
Celi M; Letizia C; Ragno A; Minisola S; D'Erasmo E; Mazzuoli GF
Minerva Med; 2002 Dec; 93(6):471-8. PubMed ID: 12515970
[TBL] [Abstract][Full Text] [Related]
29. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
[TBL] [Abstract][Full Text] [Related]
30. Comparison of different treatment modalities for postmenopausal patients with osteopenia: hormone replacement therapy, calcitonin and clodronate.
Tiraş MB; Noyan V; Yildiz A; Biberoğlu K
Climacteric; 2000 Jun; 3(2):92-101. PubMed ID: 11910657
[TBL] [Abstract][Full Text] [Related]
31. A randomized, multicenter controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with elcatonin in postmenopausal women with osteoporosis in China.
Zhang XZ; Wang B; Yang J; Xuan M; Song LG; Li H; Guo XH; Lü XF; Xue QY; Yang GY; Ji QH; Shen J; Liu ZM; Li CJ; Wu TF; Tong XC; Jia Y
Chin Med J (Engl); 2009 Dec; 122(24):2933-8. PubMed ID: 20137477
[TBL] [Abstract][Full Text] [Related]
32. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency.
Finkelstein JS; Klibanski A; Schaefer EH; Hornstein MD; Schiff I; Neer RM
N Engl J Med; 1994 Dec; 331(24):1618-23. PubMed ID: 7969342
[TBL] [Abstract][Full Text] [Related]
33. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
[TBL] [Abstract][Full Text] [Related]
34. Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants.
Holland EF; Studd JW; Mansell JP; Leather AT; Bailey AJ
Obstet Gynecol; 1994 Feb; 83(2):180-3. PubMed ID: 8290178
[TBL] [Abstract][Full Text] [Related]
35. Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
Adami S; Passeri M; Ortolani S; Broggini M; Carratelli L; Caruso I; Gandolini G; Gnessi L; Laurenzi M; Lombardi A
Bone; 1995 Oct; 17(4):383-90. PubMed ID: 8573412
[TBL] [Abstract][Full Text] [Related]
36. The effects of plasma estradiol levels on increases in vertebral and femoral bone density following therapy with estradiol and estradiol with testosterone implants.
Garnett T; Studd J; Watson N; Savvas M; Leather A
Obstet Gynecol; 1992 Jun; 79(6):968-72. PubMed ID: 1579324
[TBL] [Abstract][Full Text] [Related]
37. Estrogen treatment of patients with established postmenopausal osteoporosis.
Lindsay R; Tohme JF
Obstet Gynecol; 1990 Aug; 76(2):290-5. PubMed ID: 2371033
[TBL] [Abstract][Full Text] [Related]
38. [Biochemical markers of bone remodeling and bone density in healthy postmenopausal women].
Campusano C; López JM; González G; Rojas A; Arteaga E; Rodríguez J
Rev Med Chil; 1993 Sep; 121(9):1000-5. PubMed ID: 8191148
[TBL] [Abstract][Full Text] [Related]
39. The effect of 25-mg percutaneous estradiol implants on the bone mass of postmenopausal women.
Holland EF; Leather AT; Studd JW
Obstet Gynecol; 1994 Jan; 83(1):43-6. PubMed ID: 8272305
[TBL] [Abstract][Full Text] [Related]
40. [Observations on bone mineral metabolism in natural and surgical menopause. Role of synthetic salmon calcitonin and calcium on bone turnover].
Ferrante B; Isa L; Uderzo A
Minerva Ginecol; 1993 Mar; 45(3):87-93. PubMed ID: 8332282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]